Babcock Full Year Results: Strong Underlying Growth Amid Type 31 Charge and Increased Shareholder Returns

Babcock FY26 results explained: revenue growth, Type 31 pain and a bigger payout

Babcock’s full year results are a classic case of two stories happening at once. On one hand, the group delivered stronger revenue, better cash generation, lower net debt and higher shareholder returns. On the other, a hefty £140.0 million charge on the Type 31 frigate contract took a big bite out of reported profit and earnings.

My take: this is a good underlying result with one very obvious black mark. If you strip out the Type 31 problem, Babcock looks like a business with real momentum in defence and nuclear. But that contract issue is too large to shrug off, so investors are right to pay close attention.

Babcock FY26 key numbers at a glance

Metric	FY26	FY25
Revenue	£5,177.7 million	£4,831.3 million
Operating profit	£305.1 million	£363.9 million
Underlying operating profit	£293.3 million	£362.9 million
Underlying operating profit excluding Type 31 charge	£433.3 million	£362.9 million
Underlying operating margin	5.7%	7.5%
Underlying operating margin excluding Type 31 charge	8.2%	7.5%
Underlying EPS	39.6p	50.3p
Underlying EPS excluding Type 31 charge	60.5p	50.3p
Underlying free cash flow	£261.8 million	£153.4 million
Net debt	£329.0 million	£373.3 million
Full year dividend	7.5p	6.5p

Type 31 charge explained: the issue that distorted Babcock’s profits

The main problem here is the Type 31 frigate programme. Babcock booked a £140.0 million charge to cover the remaining cost of the contract, after higher-than-expected rework during the outfitting of ship one and updated cost estimates for the rest of the programme.

This matters because the charge includes a £95.5 million revenue reversal. In plain English, Babcock had to pull back revenue it had previously expected to recognise, because the contract economics worsened. That dragged group revenue, profit, margin and earnings lower in FY26.

The company says the cash costs will come over the remainder of the contract, not all at once. That softens the balance sheet hit in the short term, but it does not remove the bigger concern – execution risk on fixed-price defence contracts can get expensive fast.

To Babcock’s credit, it has now taken the full charge in FY26. That gives investors a cleaner base for FY27, but it also means management has no room for another nasty surprise here.

Underlying Babcock performance was stronger than the headline numbers suggest

Strip out Type 31 and the picture improves a lot. Revenue grew 8% organically, which means growth from the existing business excluding currency and acquisitions. That is solid, especially for a company serving long-cycle defence and nuclear markets.

Even better, underlying operating profit excluding the Type 31 charge rose 19% to £433.3 million, while the underlying operating margin improved to 8.2%. That is above Babcock’s 8.0% target, which tells you the core business is performing better than the reported numbers imply.

Underlying EPS excluding the charge climbed 20% to 60.5p. For retail investors, that is one of the clearest signs that this was not a weak trading year overall – it was a good year overshadowed by one contract.

Nuclear and Aviation were the standout performers

• Nuclear revenue rose 14% and underlying operating profit increased 23% to £197.1 million, with margin improving to 9.5%.
• Aviation revenue jumped 34% and underlying operating profit increased 54% to £30.7 million.
• Land revenue fell 3%, but profit still rose 11% to £95.3 million, showing better mix and margins.
• Marine was hit hardest by Type 31, posting an underlying operating loss of £29.8 million. Excluding the charge, Marine profit would have been £110.2 million.

Babcock cash flow, net debt and shareholder returns look genuinely strong

This is where the results get more reassuring. Underlying free cash flow rose 71% to £261.8 million, while underlying operating cash conversion reached 119%. Cash conversion measures how well profit turns into cash, and anything above 100% gets attention.

Net debt reduced to £329.0 million, while net debt excluding leases fell to just £22.7 million. The covenant gearing ratio was only 0.2x, comfortably below the group’s maximum covenant limit of 3.5x. In short, the balance sheet looks strong.

That strength is feeding through to shareholder returns. Babcock lifted the full year dividend by 15% to 7.5p, completed a £200 million share buyback in April 2026, and has announced another £200 million buyback for FY27.

I see that as a meaningful signal. Companies do not usually ramp up dividends and buybacks like this unless management is confident about cash generation.

Contract backlog fell, but the growth pipeline still looks serious

Contract backlog slipped to £9.8 billion from £10.4 billion. That is not ideal on the face of it, but it reflects ongoing contract execution and the timing of major awards won in FY25.

More importantly, Babcock says around 70% of FY27 revenue was already under contract at 1 April 2026. That gives good visibility, especially in defence and nuclear where procurement cycles are long and demand is increasingly shaped by geopolitics and energy security.

The strategic pipeline also looks interesting. Highlights include the Indonesia maritime framework worth up to £4 billion, a role on Great British Energy-Nuclear’s UK small modular reactor programme, and deeper work with HII on US submarine programmes.

Babcock outlook for FY27: unchanged guidance is encouraging

Despite the Type 31 setback, Babcock left FY27 expectations unchanged and reiterated its medium-term guidance. That includes average mid-single digit organic revenue growth, an underlying operating margin of at least 9% and average underlying operating cash conversion of at least 80%.

That is encouraging because management could easily have turned more cautious. Instead, they are effectively saying the Type 31 pain is contained and the rest of the business remains on track.

What Babcock investors should watch next after these full year results

For me, there are three big watchpoints. First, whether Type 31 now behaves and does not generate further charges. Second, whether Nuclear can keep delivering high-margin growth. Third, whether the backlog converts into fresh major wins, especially in defence nuclear and international naval programmes.

There is also a leadership handover coming, with Harry Holt set to become CEO on 1 August. Succession always adds a little uncertainty, but the company is presenting this as a planned transition rather than a reset.

Final verdict on Babcock FY26 results

This was better than the headline suggests, but not clean enough to call a slam dunk. The underlying business is clearly improving, cash performance is strong, and shareholder returns are moving up nicely. Those are all positives.

The negative is obvious: Type 31 was a costly reminder that contract risk never really goes away in this industry. If that issue is now properly boxed off, these results could mark another step forward in Babcock’s recovery. If not, investors will get less patient very quickly.

On balance, I’d call this a cautiously positive update. The core engine looks stronger. The question is whether management has finally cleared the biggest operational pothole in the road.